Trials / Recruiting
RecruitingNCT07273136
Combined Subcostal and Lateral Transversus Abdominis Plane Block for Postoperative Analgesia Versus Thoracic Epidural Analgesia in Patients Undergoing Major Abdominal Cancer Surgery
Safety and Efficacy of Combined Subcostal and Lateral Transversus Abdominis Plane Block for Postoperative Analgesia Versus Thoracic Epidural Analgesia in Patients Undergoing Major Abdominal Cancer Surgery
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the safety and efficacy of combined subcostal and lateral transversus abdominis plane (TAP) for postoperative analgesia versus thoracic epidural anesthesia (TEA) in patients undergoing major abdominal cancer surgery.
Detailed description
Postoperative pain is treated using a variety of techniques. It is possible to deliver opioids intravenously, neuraxially, or both. Thoracic epidural anesthesia (TEA) has long been considered the benchmark for analgesia in major abdominal operations due to its consistent efficacy in pain control and additional benefits such as reduced ileus and improved pulmonary function. Transversus abdominis plane (TAP) blocks can be a critical component of postoperative pain management, and they play a crucial role in Enhanced Recovery After Surgery (ERAS) protocols, as they significantly affect recovery and patient well-being.
Conditions
- Subcostal
- Lateral
- Transversus Abdominis Plane Block
- Postoperative Analgesia
- Thoracic Epidural Analgesia
- Major Abdominal Cancer Surgery
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Subcostal and lateral transversus abdominis plane block | Patients will receive an ultrasound-guided combined subcostal and lateral transversus abdominis plane block. |
| OTHER | Thoracic epidural anesthesia | Patients will receive an ultrasound-guided thoracic epidural anesthesia. |
Timeline
- Start date
- 2025-12-10
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2025-12-09
- Last updated
- 2025-12-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07273136. Inclusion in this directory is not an endorsement.